InvestorsHub Logo
Followers 116
Posts 1878
Boards Moderated 0
Alias Born 11/22/2017

Re: longfellow95 post# 235118

Sunday, 06/30/2019 5:33:41 PM

Sunday, June 30, 2019 5:33:41 PM

Post# of 704559

I don't have any axe to grind here, but it seems to me that some DCVaxL manufacture for the trial likely did occur in the UK at Kings, between 2013 and 2015.



longfellow95,

It seems to me that ALL DCVax-L manufacture for the TRIAL (European patients) did occur at Fraunhofer IZI Germany.


Fraunhofer IZI Annual Report 2013 Page 23

a real highlight of 2013 was when we started to manufacture and conduct quality controls for investigational medicinal products with regard to two of our key projects: CVac™ on behalf of Prima BioMed Ltd. and DCVax®-L for Northwest Biotherapeutics Inc./Cognate BioServices Inc.

https://www.izi.fraunhofer.de/content/dam/izi/en/documents/Publications/Annual_Report_IZI_2013.pdf

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News